> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 6 New, 30 Updated Medication Guides
- URL: https://www.fdaweb.com/6-new-30-updated-medication-guides/
- Published: 2018-04-27T12:00:00.000Z
- Updated: 2026-09-15T00:01:41.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5141315

FDA has issued a [list](https://www.fda.gov/Drugs/DrugSafety/ucm085729.htm?ref=fdaweb.com) of Medication Guides, showing six that are new and 30 that have been updated since 3/2017\. New guides were issued for Kempharm’s Apadaz, Merck’s Ilumya, Bracco Diagnostics’ Multihance, Intercept Pharmaceuticals’ Ocaliva, Synergy Pharmaceuticals’ Trulance, and rtis’ Zortress.

Guides were updated for AstraZeneca’s Brilinta, UCB’s Cimzia, Novartis’ Cosentyx, West-Ward’s Dolophine, Takeda’s Entyvio, Apopharma’s Ferriprox, MedImmune’s Imfinzi, Merck’s Janumet and Janumet XR, Regeneron’s Kevzara, Sunovion’s Latuda, AstraZeneca’s Lynparza, AstraZeneca’s Movantik, NSAID, Bristol-Myers Squibb’s Opdivo, Celgene’s Pomalyst, Boehringer Ingelheim’s Pradaxa, Wyeth’s Pristiq, Otsuka’s Rexulti, Otsuka’s Samsca, Janssen’s Simponi and Simponi Aria, Indivior’s Suboxone, Indivior’s Subutex, Shionogi’s Symproic, Novartis’ Tasigna, Allergan’s Viberzi, Bristol-Myers Squibb’s Videx, Bristol-Myers Squibb’s Yervoy, and Gilead’s Zydelig.